ADVANDX
AdvanDx is a leading provider of rapid and accurate molecular diagnostic tests for the identification of pathogens causing critical infections in hospitalized patients. Its mission is to help healthcare providers optimize antibiotic therapy earlier in order to improve patient outcomes while limiting unnecessary antibiotic use and reducing hospital costs. AdvanDx was founded in 2002 and headquartered in Woburn, Massachusetts.
ADVANDX
Industry:
Biotechnology Health Care Hospital Medical Device
Founded:
2002-01-01
Address:
Woburn, Massachusetts, United States
Country:
United States
Website Url:
http://www.advandx.com
Total Employee:
11+
Status:
Active
Contact:
(866) 376-0009
Email Addresses:
[email protected]
Total Funding:
49.7 M USD
Technology used in webpage:
Domain Not Resolving CloudFront
Similar Organizations
![]()
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Lucira Health
Lucira Health is a biotechnology company that offers disposable test kits to detect RNA and DNA of infectious diseases.
![]()
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Jefferson Health System
Jefferson Health System is a health care company that offers an extended care community for personal health.
![]()
Mobile Medical
MMIC is a diverse company offering both commercial and military/disaster readiness product lines for domestic and international markets.
SomaLogic
SomaLogic is a protein biomarker discovery and clinical diagnostics company, offers SOMAmer technology to improve diagnostic products.
Current Advisors List
![]()
![]()

![]()
![]()
Founder
Investors List
![]()
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Venture Round - AdvanDx
![]()
SLS Venture
SLS Venture investment in Venture Round - AdvanDx
![]()
LD Pensions
LD Pensions investment in Venture Round - AdvanDx
![]()
LD Pensions
LD Pensions investment in Series C - AdvanDx
![]()
SLS Venture
SLS Venture investment in Series C - AdvanDx
![]()
LD Pensions
LD Pensions investment in Series C - AdvanDx
![]()
SLS Venture
SLS Venture investment in Series C - AdvanDx
![]()
bioMerieux
bioMerieux investment in Series C - AdvanDx
![]()
SLS Venture
SLS Venture investment in Series B - AdvanDx
![]()
LD Pensions
LD Pensions investment in Series B - AdvanDx
